1. Home
  2. DAKT vs OLMA Comparison

DAKT vs OLMA Comparison

Compare DAKT & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

SELL

Current Price

$18.63

Market Cap

846.9M

Sector

Industrials

ML Signal

SELL

Logo Olema Pharmaceuticals Inc.

OLMA

Olema Pharmaceuticals Inc.

HOLD

Current Price

$7.04

Market Cap

949.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
OLMA
Founded
1968
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
846.9M
949.3M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
DAKT
OLMA
Price
$18.63
$7.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
12
Target Price
$32.00
★ $36.50
AVG Volume (30 Days)
452.0K
★ 1.2M
Earning Date
09-02-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 538.10
15.00
EPS
★ 0.40
N/A
Revenue
★ $608,932,000.00
N/A
Revenue This Year
$7.05
N/A
Revenue Next Year
$8.01
N/A
P/E Ratio
$45.63
★ N/A
Revenue Growth
★ 6.89
N/A
52 Week Low
$16.77
$6.65
52 Week High
$28.27
$36.26

Technical Indicators

Market Signals
Indicator
DAKT
OLMA
Relative Strength Index (RSI) 58.28 19.25
Support Level $16.77 N/A
Resistance Level $20.84 $11.27
Average True Range (ATR) 0.40 0.42
MACD 0.19 -0.08
Stochastic Oscillator 98.11 2.25

Price Performance

Historical Comparison
DAKT
OLMA

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Share on Social Networks: